Genzyme Corporation : AP Business NewsBrief at 7:16 A.m. EST

Published January 16, 2014

Genzyme Corporation : AP Business NewsBrief at 7:16 a.m. EST
PARIS (AP) _ The U.S. Food and Drug Administration has notified drug maker Genzyme that its treatment for multiple sclerosis is not ready for approval for the American market. The French pharmaceutical company Sanofi , which is the parent of Genzyme …
Read more on 4-traders (press release)